News
A new version of the McDonald criteria — the official guidelines used to diagnose MS — aim to make MS diagnosis faster and ...
An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The McDonald Diagnostic Criteria for MS - a set of guidelines to help healthcare ...
News-Medical.Net on MSN
Researchers receive new funding to advance promising therapy for multiple sclerosis
A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) ...
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a Phase 3 clinical study titled ‘A Randomized, ...
Dr Jiwon Oh looks forward to hearing updates on major clinical trials and long-term studies of new and emerging MS treatments at ECTRIMS 2025.
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a Phase 3 clinical study titled ...
A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance ...
OMAHA, Neb. (WOWT) - She’s pioneering a journey in medicine. A Nebraska woman has become the first patient in the world to undergo a groundbreaking new treatment for multiple sclerosis. “I really was ...
BRIUMVI is indicated in the U.S. for the treatment of adults with RMS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease and in the EU and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results